Literature DB >> 10351186

Valuing health-related quality of life. Issues and controversies.

P Dolan1.   

Abstract

An important consideration when establishing priorities in healthcare is the likely effect that alternative allocations will have on the health-related quality of life (HR-QOL) of the relevant population. This paper considers some of the important issues and controversies surrounding the valuation of HR-QOL. It considers the theoretical and empirical evidence regarding 3 crucial questions: (i) what is to be valued?; (ii) how is it to be valued?; and (iii) who is to value it? Many important yet unresolved issues emerge and directions for future research are suggested. It is argued that this research agenda should have the gathering and analysis of qualitative data at its forefront.

Mesh:

Year:  1999        PMID: 10351186     DOI: 10.2165/00019053-199915020-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  34 in total

1.  The time trade-off: a note on the effect of lifetime reallocation of consumption and discounting.

Authors:  P Dolan; M Jones-Lee
Journal:  J Health Econ       Date:  1997-12       Impact factor: 3.883

2.  Valuing health states: a comparison of methods.

Authors:  P Dolan; C Gudex; P Kind; A Williams
Journal:  J Health Econ       Date:  1996-04       Impact factor: 3.883

3.  The effect of search procedures on utility elicitations.

Authors:  L A Lenert; D J Cher; M K Goldstein; M R Bergen; A Garber
Journal:  Med Decis Making       Date:  1998 Jan-Mar       Impact factor: 2.583

4.  The measurement of utility in multiphase health states.

Authors:  J Richardson; J Hall; G Salkeld
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

5.  Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values.

Authors:  P Dolan; M Sutton
Journal:  Soc Sci Med       Date:  1997-05       Impact factor: 4.634

6.  Using conjoint analysis to assess women's preferences for miscarriage management.

Authors:  M Ryan; J Hughes
Journal:  Health Econ       Date:  1997 May-Jun       Impact factor: 3.046

7.  An experimental test of a theoretical foundation for rating-scale valuations.

Authors:  H Bleichrodt; M Johannesson
Journal:  Med Decis Making       Date:  1997 Apr-Jun       Impact factor: 2.583

8.  Quality-adjusted life years, utility theory, and healthy-years equivalents.

Authors:  A Mehrez; A Gafni
Journal:  Med Decis Making       Date:  1989 Apr-Jun       Impact factor: 2.583

9.  Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems.

Authors:  A Gafni; S Birch
Journal:  Soc Sci Med       Date:  1995-03       Impact factor: 4.634

10.  The measurement of patients' values in medicine.

Authors:  H Llewellyn-Thomas; H J Sutherland; R Tibshirani; A Ciampi; J E Till; N F Boyd
Journal:  Med Decis Making       Date:  1982       Impact factor: 2.583

View more
  10 in total

Review 1.  Testing the validity of cost-effectiveness models.

Authors:  C McCabe; S Dixon
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

2.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Quality-of-life valuations of advanced breast cancer by New Zealand women.

Authors:  Richard J Milne; Kathy H Heaton-Brown; Paul Hansen; David Thomas; Vernon Harvey; Alison Cubitt
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.

Authors:  Nan Luo; Pei Wang; Julian Thumboo; Yee-Wei Lim; Hubertus J M Vrijhoef
Journal:  Pharmacoeconomics       Date:  2014-05       Impact factor: 4.981

5.  Does diabetes have an impact on health-state utility? a study of Asians in Singapore.

Authors:  P Wang; E S Tai; J Thumboo; Hubertus J M Vrijhoef; Nan Luo
Journal:  Patient       Date:  2014       Impact factor: 3.883

Review 6.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  How do common chronic conditions affect health-related quality of life?

Authors:  Isobel T M Heyworth; Michelle L Hazell; Mary F Linehan; Timothy L Frank
Journal:  Br J Gen Pract       Date:  2009-07-24       Impact factor: 5.386

8.  Quality of life valuations of HPV-associated cancer health states by the general population.

Authors:  E Lynne Conway; K Chip Farmer; William J Lynch; Guy L Rees; Gerard Wain; Jane Adams
Journal:  Sex Transm Infect       Date:  2012-05-29       Impact factor: 3.519

9.  'Like holding the axe on who should live or not': adolescents' and adults' perceptions of valuing children's health states using a standardised valuation protocol for the EQ-5D-Y-3L.

Authors:  Mimmi Åström; Helen Conte; Jenny Berg; Kristina Burström
Journal:  Qual Life Res       Date:  2022-02-24       Impact factor: 3.440

10.  B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial.

Authors:  Valentina A Andreeva; Clotilde Latarche; Serge Hercberg; Serge Briançon; Pilar Galan; Emmanuelle Kesse-Guyot
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.